BVAXF (BioVaxys Technology) Dividend Payout Ratio : 0.00 (As of Jul. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. BioVaxys Technology's Dividend Payout Ratio for the months ended in Jul. 2024 was 0.00.

The historical rank and industry rank for BioVaxys Technology's Dividend Payout Ratio or its related term are showing as below:

BVAXF's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.48
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-12-15), the Dividend Yield % of BioVaxys Technology is 0.00%.

BioVaxys Technology's Dividends per Share for the months ended in Jul. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

BioVaxys Technology Dividend Payout Ratio Historical Data

The historical data trend for BioVaxys Technology's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Dividend Payout Ratio Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Dividend Payout Ratio

Get a 7-Day Free Trial

BioVaxys Technology Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BioVaxys Technology's Dividend Payout Ratio

For the Biotechnology subindustry, BioVaxys Technology's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioVaxys Technology's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's Dividend Payout Ratio falls into.

BioVaxys Technology Dividend Payout Ratio Calculation

BioVaxys Technology's Dividend Payout Ratio for the fiscal year that ended in Oct. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Oct. 2023 )	/	EPS without NRI (A: Oct. 2023 )
	=	0	/	-0.036
	=	N/A

BioVaxys Technology's Dividend Payout Ratio for the quarter that ended in Jul. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jul. 2024 )	/	EPS without NRI (Q: Jul. 2024 )
	=	0	/	-0.006
	=	N/A

BioVaxys Technology (OTCPK:BVAXF) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

BioVaxys Technology Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The company's clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its proprietary HapTenix 'neoantigen' tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer.